Brief: Innovative Pharmaceutical Biotech Signs MOU In Relation To Possible Investment
Sept 4 (Reuters) - Innovative Pharmaceutical Biotech Ltd
0399.HK :
* MEMORANDUM OF UNDERSTANDING IN RELATION TO POSSIBLE
INVESTMENT
* COMPANY ENTERED INTO MOU WITH NIRAXX. INC
* MOU IN RESPECT OF POSSIBLE INVESTMENT IN RESPECT OF
MAJORITY
STAKE IN NIRAXX. INC
Source text for Eikon: ID:
Further company coverage: 0399.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU